Old Articles: <Older 8911-8920 Newer> |
|
HBS Working Knowledge August 18, 2014 Carmen Nobel |
Have a Better Idea To Improve Health Care? A collaboration between Harvard Business School and Harvard Medical School seeks to promote already proven innovations that could increase the quality and lower the cost of health care. |
Chemistry World August 12, 2014 Simon Hadlington |
Knock-out theory puts new spin on general anesthesia Consciousness may be extinguished through mysterious quantum biological effects that cause subtle changes in the electronic state of proteins, say researchers. |
Chemistry World August 12, 2014 Phillip Broadwith |
Sanofi snaps up inhaled insulin license Sanofi has struck a licensing deal with US firm Mannkind to develop and commercialize Mannkind's recently-approved Afrezza inhaled insulin powder for global distribution. |
Information Today August 12, 2014 |
New IEEE Journal Will Focus on Life Sciences IEEE will publish IEEE Life Sciences Letters, a peer-reviewed, open access journal, in 1Q 2015. |
Chemistry World August 11, 2014 Phillip Broadwith |
Single shot antibiotic approved for skin infections Intravenous antibiotic Orbactiv oritavancin, from US firm The Medicines Company, has been approved by the US Food and Drug Administration. |
Pharmaceutical Executive August 1, 2014 William Looney |
A Mission to Transform Mid-career students at Brown University's new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos. |
Pharmaceutical Executive August 1, 2014 Ben Comer |
Pharm Exec's 2014 Emerging Pharma Leaders This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise. |
Pharmaceutical Executive August 1, 2014 |
Country Report: Chile 2014 kicks off a defining period for healthcare in Chile as a new national drug law is implemented |
Pharmaceutical Executive August 1, 2014 Severin Wirz |
Only Fools Rush In The importance of pre-acquisition due diligence. |
Pharmaceutical Executive August 1, 2014 |
EFPIA's 'Integrated Strategy' in Europe: Out of the Frying Pan, Into the Fire? Industry's grand vision for reshaping the life sciences in Europe may ultimately prove to be a lost cause. |
<Older 8911-8920 Newer> Return to current articles. |